Cite
Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis.
MLA
Yao, Hualiang, et al. “Design and Synthesis of Highly Selective Janus Kinase 3 Covalent Inhibitors for the Treatment of Rheumatoid Arthritis.” Archiv Der Pharmazie, vol. 357, no. 6, June 2024, p. e2300753. EBSCOhost, https://doi.org/10.1002/ardp.202300753.
APA
Yao, H., Zhang, J., Zheng, Q., Zeng, X., Huang, H., Ling, Z., Tang, M., Chen, Z., Wang, W., & He, L. (2024). Design and synthesis of highly selective Janus kinase 3 covalent inhibitors for the treatment of rheumatoid arthritis. Archiv Der Pharmazie, 357(6), e2300753. https://doi.org/10.1002/ardp.202300753
Chicago
Yao, Hualiang, Jie Zhang, Qisheng Zheng, Xianxia Zeng, Huaizheng Huang, Zhen Ling, Minghai Tang, Zhiquan Chen, Wenchu Wang, and Linhong He. 2024. “Design and Synthesis of Highly Selective Janus Kinase 3 Covalent Inhibitors for the Treatment of Rheumatoid Arthritis.” Archiv Der Pharmazie 357 (6): e2300753. doi:10.1002/ardp.202300753.